Peter Garcia
2018 - PDL BioPharma
In 2018, Peter Garcia earned a total compensation of $2.1M as Vice President and Chief Financial Officer at PDL BioPharma, a 53% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $479,033 |
|---|---|
| Option Awards | $1,131,398 |
| Salary | $452,000 |
| Other | $54,000 |
| Total | $2,116,431 |
Garcia received $1.1M in option awards, accounting for 53% of the total pay in 2018.
Garcia also received $479K in non-equity incentive plan, $452K in salary and $54K in other compensation.
Rankings
In 2018, Peter Garcia's compensation ranked 5,433rd out of 14,244 executives tracked by ExecPay. In other words, Garcia earned more than 61.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,433 out of 14,244 | 62nd |
Division Manufacturing | 2,049 out of 5,765 | 65th |
Major group Chemicals And Allied Products | 748 out of 2,128 | 65th |
Industry group Drugs | 628 out of 1,817 | 65th |
Industry Biological Products, Except Diagnostic Substances | 128 out of 339 | 62nd |
Source: SEC filing on April 30, 2019.
Garcia's colleagues
We found four more compensation records of executives who worked with Peter Garcia at PDL BioPharma in 2018.
News
ALX ONCOLOGY HOLDINGS CEO Jason Lettmann receives $4.9M in 2023
April 22, 2024
ALX ONCOLOGY HOLDINGS CEO Jaume Pons' 2022 pay falls 63% to $3.7M
April 24, 2023
PDL BioPharma CEO Dominique Monnet's 2019 pay jumps 168% to $6.7M
July 7, 2020
PDL BioPharma CEO John McLaughlin's 2018 pay rises 20% to $4.1M
April 30, 2019